| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| SARC | ENSG00000185670 | ZBTB3 | Natural Killer Cell Cytotoxicity | 2.237e-03 | 6.102e-03 | -0.3965 | -0.9955 | 33 |
| SARC | ENSG00000185670 | ZBTB3 | TCR signaling Pathway | 2.174e-03 | 6.102e-03 | -0.5021 | -0.9957 | 29 |
| SARC | ENSG00000173011 | TADA2B | TCR signaling Pathway | 2.358e-03 | 4.009e-02 | 0.51 | 0.9953 | 31 |
| SARC | ENSG00000009950 | MLXIPL | Cytokines | 1.142e-03 | 1.941e-02 | 0.4099 | 0.9977 | 106 |
| SARC | ENSG00000173917 | HOXB2 | Chemokines | 1.499e-03 | 1.274e-02 | 0.4729 | 0.997 | 18 |
| SARC | ENSG00000173917 | HOXB2 | Cytokines | 1.277e-03 | 1.274e-02 | 0.3641 | 0.9974 | 71 |
| SARC | ENSG00000180257 | ZNF816 | Antigen Processing and Presentation | 1.799e-03 | 1.529e-02 | -0.5682 | -0.9964 | 50 |
| SARC | ENSG00000180257 | ZNF816 | Antimicrobials | 1.715e-03 | 1.529e-02 | -0.4025 | -0.9966 | 104 |
| SARC | ENSG00000122034 | GTF3A | Antigen Processing and Presentation | 2.105e-03 | 3.184e-02 | 0.4119 | 0.9958 | 41 |
| SARC | ENSG00000143190 | POU2F1 | Antigen Processing and Presentation | 1.684e-03 | 2.104e-02 | -0.4668 | -0.9966 | 51 |
| SARC | ENSG00000143190 | POU2F1 | TCR signaling Pathway | 2.475e-03 | 2.104e-02 | 0.4299 | 0.995 | 29 |
| SARC | ENSG00000103449 | SALL1 | Cytokines | 1.041e-03 | 1.769e-02 | 0.3773 | 0.9979 | 116 |
| SARC | ENSG00000196646 | ZNF136 | Antigen Processing and Presentation | 2.000e-03 | 3.400e-02 | -0.492 | -0.996 | 44 |